Clinical Trial 51268

Dallas, TX 75231


This depression study is a phase 2/3, randomized, double-blind, placebo-controlled study to evaluate an investigational drug in adults diagnosed with major depressive disorder (MDD) who are currently depressed and have used an antidepressant medication without sufficient improvement in their depression symptoms. The investigational drug is an oral medication that is taken daily along with an approved antidepressant treatment for 14 weeks

To pre-qualify for this study, you must:

  • Be 18 to 65 years of age
  • Have been diagnosed with MDD and currently be experiencing a depressive episode
  • Have used at least 1 but not more than 3 antidepressant medications without sufficient improvement in your depression symptoms

Additional criteria will apply

Qualified Participants May Receive:

. All study-related visits, tests, and drugs will be provided at no cost. You may also be reimbursed for study-related travel expenses.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.